Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
EMBO J
2002 Feb 15;214:580-9. doi: 10.1093/emboj/21.4.580.
Show Gene links
Show Anatomy links
Activation of system L heterodimeric amino acid exchangers by intracellular substrates.
Meier C
,
Ristic Z
,
Klauser S
,
Verrey F
.
???displayArticle.abstract???
System L-type transport of large neutral amino acids is mediated by ubiquitousLAT1-4F2hc and epithelial LAT2-4F2hc. These heterodimers are thought to function as obligatory exchangers, but only influx properties have been studied in some detail up until now. Here we measured their intracellular substrate selectivity, affinity and exchange stoichiometry using the Xenopus oocyte expression system. Quantification of amino acid influx and efflux by HPLC demonstrated an obligatory amino acid exchange with 1:1 stoichiometry. Strong, differential trans-stimulations of amino acid influx by injected amino acids showed that the intracellular substrate availability limits the transport rate and that the efflux selectivity range resembles that of influx. Compared with high extracellular apparent affinities, LAT1- and LAT2-4F2hc displayed much lower intracellular apparent affinities (apparent K(m) in the millimolar range). Thus, the two system L amino acid transporters that are implicated in cell growth (LAT1-4F2hc) and transcellular transport (LAT2-4F2hc) are obligatory exchangers with relatively symmetrical substrate selectivities but strongly asymmetrical substrate affinities such that the intracellular amino acid concentration controls their activity.
Albers,
Na+ transport by the neural glutamine transporter ATA1.
2001, Pubmed,
Xenbase
Albers,
Na+ transport by the neural glutamine transporter ATA1.
2001,
Pubmed
,
Xenbase
Bassi,
SLC7A8, a gene mapping within the lysinuric protein intolerance critical region, encodes a new member of the glycoprotein-associated amino acid transporter family.
1999,
Pubmed
,
Xenbase
Boado,
Selective expression of the large neutral amino acid transporter at the blood-brain barrier.
1999,
Pubmed
,
Xenbase
Campbell,
Overexpression of LAT1/CD98 light chain is sufficient to increase system L-amino acid transport activity in mouse hepatocytes but not fibroblasts.
2001,
Pubmed
Campbell,
TA1/LAT-1/CD98 light chain and system L activity, but not 4F2/CD98 heavy chain, respond to arginine availability in rat hepatic cells. Loss Of response in tumor cells.
2000,
Pubmed
Chairoungdua,
Identification of an amino acid transporter associated with the cystinuria-related type II membrane glycoprotein.
1999,
Pubmed
Divino Filho,
Free amino-acid levels simultaneously collected in plasma, muscle, and erythrocytes of uraemic patients.
1997,
Pubmed
Duelli,
Expression of large amino acid transporter LAT1 in rat brain endothelium.
2000,
Pubmed
Feliubadaló,
Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.
1999,
Pubmed
Jansson,
Amino acid transporters in the human placenta.
2001,
Pubmed
Kageyama,
Distribution of the 4F2 light chain, LAT1, in the mouse brain.
2000,
Pubmed
Kanai,
Transport properties of a system y+L neutral and basic amino acid transporter. Insights into the mechanisms of substrate recognition.
2000,
Pubmed
,
Xenbase
Kanai,
Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98).
1998,
Pubmed
,
Xenbase
Kim,
Expression cloning of a Na+-independent aromatic amino acid transporter with structural similarity to H+/monocarboxylate transporters.
2001,
Pubmed
,
Xenbase
Kudo,
Heterodimeric amino acid transporters: expression of heavy but not light chains of CD98 correlates with induction of amino acid transport systems in human placental trophoblast.
2000,
Pubmed
Kudo,
Characterisation of L-tryptophan transporters in human placenta: a comparison of brush border and basal membrane vesicles.
2001,
Pubmed
Mastroberardino,
Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family.
1998,
Pubmed
,
Xenbase
Matsuo,
Expression of a system L neutral amino acid transporter at the blood-brain barrier.
2000,
Pubmed
Nakamura,
4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer.
1999,
Pubmed
,
Xenbase
Pfeiffer,
Luminal heterodimeric amino acid transporter defective in cystinuria.
1999,
Pubmed
,
Xenbase
Pfeiffer,
Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family.
1999,
Pubmed
,
Xenbase
Pineda,
Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.
1999,
Pubmed
,
Xenbase
Prasad,
Human LAT1, a subunit of system L amino acid transporter: molecular cloning and transport function.
1999,
Pubmed
Rajan,
Cloning and functional characterization of a Na(+)-independent, broad-specific neutral amino acid transporter from mammalian intestine.
2000,
Pubmed
Reimer,
Amino acid transport system A resembles system N in sequence but differs in mechanism.
2000,
Pubmed
Ritchie,
Role of the System L permease LAT1 in amino acid and iodothyronine transport in placenta.
2001,
Pubmed
Rossier,
LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.
1999,
Pubmed
,
Xenbase
Segawa,
Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity.
1999,
Pubmed
,
Xenbase
Sugawara,
Cloning of an amino acid transporter with functional characteristics and tissue expression pattern identical to that of system A.
2000,
Pubmed
,
Xenbase
Sugawara,
Structure and function of ATA3, a new subtype of amino acid transport system A, primarily expressed in the liver and skeletal muscle.
2000,
Pubmed
,
Xenbase
Taylor,
Accumulation of free amino acids in growing Xenopus laevis oocytes.
1987,
Pubmed
,
Xenbase
Teixeira,
Primary structure of the human 4F2 antigen heavy chain predicts a transmembrane protein with a cytoplasmic NH2 terminus.
1987,
Pubmed
Torrents,
Identification and characterization of a membrane protein (y+L amino acid transporter-1) that associates with 4F2hc to encode the amino acid transport activity y+L. A candidate gene for lysinuric protein intolerance.
1998,
Pubmed
,
Xenbase
Varoqui,
Cloning and functional identification of a neuronal glutamine transporter.
2000,
Pubmed
Verrey,
Glycoprotein-associated amino acid exchangers: broadening the range of transport specificity.
2000,
Pubmed
Verrey,
New glycoprotein-associated amino acid transporters.
1999,
Pubmed
Wolf,
Expression of a highly conserved oncofetal gene, TA1/E16, in human colon carcinoma and other primary cancers: homology to Schistosoma mansoni amino acid permease and Caenorhabditis elegans gene products.
1996,
Pubmed
